Tenofovir (Viread(R)) access for poor countries.
Gilead Sciences announced that it will make its drug tenofovir available at cost in all of Africa, and in some of the poorest countries elsewhere.
James
John S
JS
D000225:Adenine / Q000031:analogs & derivatives* / Q000600:supply & distribution* / Q000627:therapeutic use; D003906:Developing Countries; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000600:supply & distribution* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000600:supply & distribution* / Q000627:therapeutic use; D000068698:Tenofovir
D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine